🔎 Trials Near Me

Dachaigh › Liomfoma Neo-Hodgkin › New York › Greenburgh

Sgrùdaidhean clionaigeach Liomfoma Neo-Hodgkin ann an Greenburgh, NY

Tha 5 sgrùdaidhean airson Liomfoma Neo-Hodgkin a’ lorg phàirtichean aig làraichean ann agus timcheall air Greenburgh (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

A’ fastadhÌre 2
  • Phelps Hospital, Sleepy Hollow · 4 mìle air falbh
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT02693535

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

A’ fastadhSgrùdadh amharc
  • Memorial Sloan Kettering Bergen (Consent Only), Montvale · 9 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07249528

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

A’ fastadhÌre 1/2
  • New York Medical College, Valhalla · 5 mìle air falbh
Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

A’ fastadhÌre 2
  • New York Medical College, Valhalla · 5 mìle air falbh
Aoisean 3 gu 31 · Gach gnè · Air ùrachadh 8 Lùna 2025 · NCT02393157

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

A’ fastadhÌre 2
  • New York Medical College, Valhalla · 5 mìle air falbh
1 Day – 30 Years · Gach gnè · Air ùrachadh 8 Lùna 2025 · NCT04099966

Sgrùdaidhean Liomfoma Neo-Hodgkin ann am bailtean eile

Sgrùdaidhean eile ann an Greenburgh

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.